Similarly, EVs derived from both platelets (CD41+; Figure 4C) and activated platelets (CD62P+; Figure 4D) also significantly increased over time at 5- and 30-days in both TIA and AIS patients, indicating a sustained activation of platelets despite appropriate treatment being started. The gene discussed is ITGA2B; the disease is transient ischemic attack.